Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

321.38
+1.420.44%
Volume:106.05K
Turnover:34.15M
Market Cap:19.34B
PE:34.89
High:324.74
Open:323.29
Low:320.54
Close:319.96
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:0.77
T/O Rate:0.18%
Dividend:4.74
Dividend Rate:1.47%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.98
PE(LYR):7.74

Loading ...

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

GlobeNewswire
·
Aug 21

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live
·
Aug 21

African Markets - Factors to Watch on Aug 21

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

BioSyent Maintains Quarterly Dividend as Specialty Healthcare Growth Continues

TIPRANKS
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live
·
Aug 21

Exchange-Traded Funds Fall as US Equities Decline After Midday

MT Newswires Live
·
Aug 21

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

Reuters
·
Aug 21

Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC

Reuters
·
Aug 21

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

TIPRANKS
·
Aug 21

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Merck is Maintained at Buy by UBS

Dow Jones
·
Aug 21

Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win

Dow Jones
·
Aug 20

Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says

MT Newswires Live
·
Aug 20